Cargando…
Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
BACKGROUND: Given that memantine is thought to decrease N-methyl-D-aspartic-acid-related (NMDA) glutamatergic hyperactivity and improve locomotion in rats, we sought to assess the drug's impact on axial symptoms in advanced Parkinson's disease (PD). METHODS: We performed a 90-day, randomis...
Autores principales: | Moreau, Caroline, Delval, Arnaud, Tiffreau, Vincent, Defebvre, Luc, Dujardin, Kathy, Duhamel, Alain, Petyt, Gregory, Hossein-Foucher, Claude, Blum, David, Sablonnière, Bernard, Schraen, Susanna, Allorge, Delphine, Destée, Alain, Bordet, Régis, Devos, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623038/ https://www.ncbi.nlm.nih.gov/pubmed/23077087 http://dx.doi.org/10.1136/jnnp-2012-303182 |
Ejemplares similares
-
Are Upper-Body Axial Symptoms a Feature of Early Parkinson’s Disease?
por: Moreau, Caroline, et al.
Publicado: (2016) -
How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022) -
Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012) -
Clinical implications of early caudate dysfunction in Parkinson’s disease
por: Pasquini, Jacopo, et al.
Publicado: (2019) -
Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)